Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) EBIT Margin (2016)

Rocket Pharmaceuticals (RCKT) has disclosed EBIT Margin for 1 consecutive years, with 4203.05% as the latest value for Q4 2016.

  • Quarterly EBIT Margin changed N/A to 4203.05% in Q4 2016 from the year-ago period, while the trailing twelve-month figure was 1704.76% through Sep 2017, changed N/A year-over-year, with the annual reading at 1658.21% for FY2015, 87209.0% up from the prior year.
  • EBIT Margin hit 4203.05% in Q4 2016 for Rocket Pharmaceuticals, up from 2042.48% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 4850.24% in Q1 2016 to a low of 2042.48% in Q3 2016.